论文部分内容阅读
咳嗽变异性哮喘(Cough variant asthma,CVA)为儿童常见疾病,发病快,患病率高,患儿发病时常伴有气道高反应性,严重的患者会形成典型的哮喘。目前该病的治疗主要采用糖皮质激素吸入治疗,但是单一地使用糖皮质激素临床效果比较有限[1]。本文回顾性地分析了2011年1月—2014年1月在我院采用黄芪颗粒联合沙美特罗/丙酸氟替卡松吸入
Cough variant asthma (Cough variant asthma, CVA) is a common disease in children, with fast onset and high prevalence. Children with asthma often have airway hyperresponsiveness when they develop the disease. Serious patients develop typical asthma. The current treatment of the disease mainly with glucocorticoid inhalation, but the single use of glucocorticoid clinical effect is limited [1]. This article retrospectively analyzed January 2011-January 2014 in our hospital with astragalus particles combined with salmeterol / fluticasone propionate inhalation